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ABSTRACT
To characterize the residues that participate in the
catalysis of DNA cleavage and rejoining by the site-
specific recombinase Tn3 resolvase, we mutated
conserved polar or charged residues in the catalytic
domain of an activated resolvase variant. We
analysed the effects of mutations at 14 residues on
proficiency in binding to the recombination site
(‘site I’), formation of a synaptic complex between
two site Is, DNA cleavage and recombination.
Mutations of Y6, R8, S10, D36, R68 and R71
resulted in greatly reduced cleavage and recombi-
nation activity, suggesting crucial roles of these six
residues in catalysis, whereas mutations of the
other residues had less dramatic effects. No
mutations strongly inhibited binding of resolvase
to site I, but several caused conspicuous changes
in the yield or stability of the synapse of two site Is
observed by non-denaturing gel electrophoresis.
The involvement of some residues in both synapsis
and catalysis suggests that they contribute to a
regulatory mechanism, in which engagement of
catalytic residues with the substrate is coupled to
correct assembly of the synapse.
INTRODUCTION
Site-speciﬁc recombinases promote programmed DNA
rearrangements in a wide variety of biological contexts.
The tyrosine recombinases and the serine recombinases
are two structurally and mechanistically distinct enzyme
families, each with hundreds of known members; their
names refer to the conserved amino acid residue whose
sidechain attacks speciﬁc DNA phosphodiesters to bring
about transient strand cleavage. Studies on the structures
and mechanisms of tyrosine recombinases and a related
group of enzymes, the Type IB topoisomerases, have led
to a quite detailed picture of the active site where the
chemical steps of DNA strand cleavage and rejoining
take place (1–3), and the roles of several conserved
residues in catalysis have been elucidated. In contrast,
much less is known about the active site of serine
recombinases, the subject of this work.
Serine recombinases share a catalytic domain which is
conserved in size (140 amino acids) and in sequence
(Figure 1). In one well-studied group of serine
recombinases which includes transposon resolvases (such
as that of Tn3) and DNA invertases, the catalytic domain
is at the N-terminus of the protein and is followed by
a small helix-turn-helix DNA-binding domain. Other
groups which include transposases and bacteriophage
integrases have diﬀerent arrangements and types of
domains (4,5). The closely related Tn3 and gd resolvases
function to resolve (that is, split into two circles)
cointegrate intermediates in replicative transposition, by
promoting a site-speciﬁc recombination reaction between
the two copies of the transposon in the cointegrate. The
recombination site, res, contains three binding sites for
resolvase dimers (Figure 2A). DNA strand breaking and
rejoining are catalysed by the resolvase bound at site I,
whereas the subunits bound at the accessory sites II and
III have regulatory functions (1). Resolvase (185 amino
acids) has two functional domains (Figure 2B). The
N-terminal domain (residues 1–140) contains the
residues that form the active site for catalysis of strand
exchange, and is involved in subunit interactions. The
C-terminal domain (residues 141–185) makes a sequence-
speciﬁc interaction with motifs in the res DNA. During
recombination, two resolvase dimers bound to site I come
together to form a tetramer. All four strands of the two
site Is are then cleaved by attack of the hydroxyl group
of a conserved resolvase serine residue (S10) on speciﬁc
phosphodiesters. The four resolvase subunits directly
involved in the reaction all thus become covalently
attached to the DNA via a phosphoserine linkage.
Strand exchange is thought to involve a rotation that
brings the cleaved DNA ends into a recombinant conﬁg-
uration, followed by rejoining of the strands by reversal of
the cleavage reaction [(1), Figure 2C].
The mechanism outlined in Figure 2C involves eight
chemical reaction steps (cleavage of four DNA strands
followed by their re-ligation), as well as a conformational
change to rearrange the cleaved DNA ends. How
resolvase executes these transactions is as yet incompletely
understood. The identiﬁcation of S10 as the nucleophile
that cleaves the phosphodiesters came from the ﬁnding
that the 50-phosphates of the cleaved DNA were
covalently joined to a serine residue in gd resolvase (6)
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and that S10, rather than the other well-conserved serine
S39, is essential for catalytic activity [(7–9), Table 1].
More recently, S10 was observed to be linked to the
50-ends of the cleaved site I DNA in crystal structures of
reaction intermediates (22,23). Curiously, S10 is not
buried in an ‘active site pocket’, but is part of a surface
loop that adopts diﬀerent conformations in diﬀerent
crystallographic gd resolvase monomers (22–27). A
number of other highly conserved residues with polar or
charged sidechains are apparent in alignments of the
amino acid sequences of serine recombinases (Figure 1),
and most of these residues are quite close to S10, suggest-
ing that they might contribute to the active site (Table 1).
The importance of some of these residues in catalysis has
been conﬁrmed by mutation studies, and functions for
some have been suggested [(1,22,28), Table 1]. However,
the structure of the active site at the point of catalysis and
the functions of a number of the putative active site
residues remain obscure. Even in the recent structures of
reaction intermediates (22,23), some of these residues are
Figure 1. Alignment of the amino acid sequences of selected serine recombinase catalytic domains. The proteins in the alignment have all been
studied in vitro and shown to catalyse conservative site-speciﬁc recombination reactions. Accession numbers are given to the right of each protein’s
name. Proteins whose names are in bold are in the resolvase-invertase group of serine recombinases (see text for details). Crystallographically
determined secondary structure elements of gd resolvase (24) are boxed and labelled above the alignment. The putative catalytic residues mutated in
this study and their equivalents in the other proteins are highlighted in yellow, along with the conserved residue E124, which was not analysed here
because it has already been shown to be non-essential for catalysis (30–32). NM resolvase contains mutations at the residues highlighted in red on the
wild-type Tn3 resolvase sequence (see ‘Materials and Methods’ section for details).
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not in close contact with the DNA, and how they might
collectively build a functional active site is not obvious.
The mechanism of catalysis by Tn3 resolvase and other
serine recombinases is expected to share common features
with the mechanisms of other enzyme-catalysed phos-
phoryl transfer reactions, including substrate orientation,
general acid–base catalysis, and transition state stabiliza-
tion. A general acid is typically proposed to donate a
proton to the leaving group, and a general base to
abstract a proton from the attacking hydroxyl group
(28,29). The acid and base may be amino acid sidechain
functional groups, although water is sometimes proposed
to fulﬁl either function. The general acids or bases
involved in catalysis by serine recombinases are still
unconﬁrmed, if indeed they exist (28).
Studies on the mechanism of serine recombinases are
made more diﬃcult by their elaborate substrate require-
ments; for Tn3/gd resolvase the substrate must have two
114 bp res sites complete with ‘accessory’ resolvase-
binding sites II and III (Figure 2A), a directly repeated
arrangement of the sites, and negative supercoiling. It can
be diﬃcult to analyse the mechanism of catalysis without
interference from eﬀects on other features of such a
complex system. However, ‘activated’ resolvase multiple
mutants that do not require the accessory binding sites,
directly repeated sites, or supercoiling have been isolated
(30–33). Some of these mutants catalyse rapid recombina-
tion between two double-stranded oligonucleotide site Is
in vitro (34). Activated resolvase variants, and analogous
mutants of the DNA invertases Hin and Gin, have been
used to study structural and mechanistic aspects of recom-
bination by the serine recombinases (1). One major
advance was the crystal structure of a synaptic intermedi-
ate comprising a tetramer of activated mutant gd
resolvase subunits and two cleaved site Is, which
revealed a ﬂat hydrophobic interface between pairs of
Figure 2. Site-speciﬁc recombination by resolvase. (A) The Tn3 (or gd) recombination site res. The boxes represent binding sites for resolvase dimers.
The lengths of the DNA segments are indicated (bp). The point within site I at which resolvase breaks and rejoins the DNA is marked by a staggered
line. Wild-type resolvase requires the complete res site, but activated mutants such as NM resolvase can catalyse recombination at site I (outlined in
blue), without sites II and III. (B) Left; crystal structure of a wild-type gd resolvase dimer bound to site I [1GDT (24)]. Right; crystal structure of a
synaptic tetramer of a gd resolvase activated mutant with two cleaved site Is [1ZR4 (22); smaller scale]. The approximate positions of the active site
residues are indicated by the red circles. The images were created with PyMOL. (C) Proposed strand exchange mechanism for serine recombinases.
The reaction occurs in a synapse comprising a recombinase tetramer and two crossover sites (site I of res in the case of resolvase). Recombinase
subunits are shown as red and blue ovals. The small circles mark the positions of the phosphodiester groups attacked by the recombinase serine
residue (S10 for Tn3/gd resolvase). Cleavage of all four DNA strands (resulting in covalent attachment of the recombinase to the DNA 50-ends by a
phosphoseryl linkage) is followed by exchange of the half-sites, then re-ligation [adapted from ref. (55)].
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subunits that is proposed to support strand exchange by a
rotation mechanism [(22), Figure 2B].
Here, we adopted a mutation-based strategy to analyse
the roles of the putative catalytic residues of Tn3
resolvase. Analogous approaches have been used very suc-
cessfully to characterize the active sites of other DNA-
cleaving enzymes including tyrosine recombinases (1,2)
and Type I topoisomerases (3,35,36). Following identiﬁ-
cation of a set of candidate catalytic residues on the basis
of their conservation and sidechain properties, we mutated
them in the context of an activated Tn3 resolvase variant,
then analysed the eﬀects of the mutations on binding to
site I, formation of a synaptic complex, and catalysis of
cleavage and recombination.
MATERIALS AND METHODS
Puriﬁcation of resolvases and plasmid DNA; in vivo assays
Methods for the construction of plasmids for expression
of resolvase mutants, resolvase overexpression and
puriﬁcation, and plasmid substrate preparation were
as described in ref. (34). The activated variant ‘NM
resolvase’ used here contains six mutations from wild-
type Tn3 resolvase: R2A E56K G101S D102Y M103I
Q105L (32). Further mutations were introduced by
cloning appropriate synthetic double-stranded oligo-
nucleotides into pFO2, an NM resolvase low-level expres-
sion plasmid. pFO2 was created by replacement of
the wild-type resolvase reading frame in pMS140 with
that of NM resolvase by exchange of a NdeI–Asp718
fragment. pMS140 is similar to pMA6811 (32) except
that some undesired restriction sites have been removed.
Full sequences of the plasmids are available on request
from WMS. Colony colour assays for recombination
activity in Escherichia coli were as in ref. (32).
In vitro assays
Plasmid recombination assays were as described in ref.
(34). The recombination reaction buﬀer (before addition
of resolvase) contained 50mM Tris–HCl (pH 8.2), 10mM
MgCl2, 0.1mM EDTA and 20 mg/ml plasmid DNA.
Addition of 0.1 volume of resolvase, diluted in a buﬀer
containing 20mM Tris–HCl (pH 7.5), 1mM DTT,
0.1mM EDTA, 1M NaCl and 50% v/v glycerol,
resulted in a ﬁnal NaCl concentration of 100mM. The
ﬁnal concentration of resolvase was 400 nM, and reactions
were at 37C for 1 h, unless stated otherwise. Assays of
resolvase-mediated DNA cleavage were similar except that
the ‘EG buﬀer’ before resolvase addition contained
50mM Tris–HCl (pH 8.2), 0.1mM EDTA, 40% v/v
ethylene glycol and 20 mg/ml plasmid DNA. Reactions
were terminated by heating at 70C for 5min, or by
adding loading buﬀer (for cleavage assays). The
products were then analysed by 1.2% agarose gel
electrophoresis (after digestion with restriction enzymes
if required). Binding/synapsis reactions were carried out
as described (34). The buﬀer prior to resolvase addition
contained 20mM Tris–HCl (pH 7.5), 10 mg/ml poly(dI/
dC), 4% w/v Ficoll and 50 nM site I DNA. The ﬁnal
resolvase concentration was 400 nM unless otherwise
stated. Samples were separated in 6.5% polyacrylamide
gels (30:0.8, acrylamide: bisacrylamide). The buﬀer in
the gel and tanks was TBE (100mM Tris base, 100mM
boric acid, 1mM EDTA; pH 8.3).
Single-strand cleavage assays
The ‘n-site I’ substrate used in single-strand cleavage
assays was assembled by annealing a 50-32P-labelled
70 bp site I top-strand oligonucleotide (sequence as in
Figure 5A) with equimolar amounts of two bottom
strand oligonucleotides, such that a nick is present at the
scissile position on the bottom strand, and the 50-hydroxyl
at the nick is phosphorylated. For the cleavage assays,
resolvase (8 mM; 2.2 ml), diluted in a buﬀer containing
20mM Tris–HCl (pH 7.5), 1mM DTT, 0.1mM EDTA,
1M NaCl and 50% v/v glycerol, was added to 20 ml
aliquots containing 25 nM n-site I DNA, 50mM Tris–
HCl (pH 8.2), 10 mg/ml poly(dI/dC) and 8% w/v Ficoll,
giving a ﬁnal resolvase concentration of 800 nM.
Reactions were incubated at 37C, and were terminated
by the addition of 0.25 volume of Stop Buﬀer [20% w/v
Ficoll, 100mM Tris base, 100mM boric acid, 1mM
Table 1. Published data on putative resolvase catalytic residues
Residues Distance from scissile
phosphate
Mutants
1GDT 1ZR4
Y6 14.9 11.3 Tn3 F; gd F (10,11)
R8 10.1 3.4 gd5 Q; Hin Q, W; Gin K (12–14)
S10 13.7 1.6 Tn3 A; gd C, La (7,15)
Q14 23.5 10.9 gd5 L, R; Hin R; b R (13,16–18)
Q19 18.7 8.8 No mutant
D36 14.6 12.1 Gin N (14)
S39 10.5 12.8 gd C (19)
R45 11.3 11.6 Hin S, H, L, C (20)
D59 29.6 26.3 gd N; b N (12,18)
D67 15.4 5.9 gd G; Hin N; Gin N (13,14,16)
R68 14.5 4.2 gd H, C; Gin H (12,14,16)
R71 4.5 11.0 gd H, L; Hin C, P, Sb; Gin Q
(14,16,17,20)
E118 10.6* 15.0 gd K; Gin K; b K (14,18,21)
R119 13.4 5.1 No mutant
R125 4.9* 18.9 gd Q; Hin Q (9,13)
The ﬁrst column lists the residues analysed here. The second and third
columns give the distance (A˚) of the sidechain functional groups
(nearest non-hydrogen atom) from the phosphorus atom of the
scissile phosphate, in the two structures shown in Figure 2B; the
gd resolvase dimer-site I structure 1GDT and the cleaved intermediate
structure 1ZR4. In 1GDT, the P atom is that of chain C, residue A20,
and the residues are in subunit B except for those marked with an
asterisk, where the residue in subunit A is closer. In 1ZR4, the P
atom is that of the phosphate attached to S10 of subunit A, and all
the residues are in subunit A. The ﬁnal column summarizes previously
reported mutations of the residues. Those studied in vitro are in bold,
and those studied only in vivo are in plain text. Mutations that abol-
ished recombination activity are in red, and those that did not are in
black. Relevant references are given in square brackets.
aMutants of the residue corresponding to S10 have been created for
several serine recombinases; all are reported as being inactive in vivo
and/or in vitro.
bA number of other mutations of this residue in Hin abolished activity
in vivo (20).
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EDTA (pH 8.3), 0.5% w/v sodium dodecyl sulphate
(SDS), 1mg/ml protease K and 0.5 mg/ml bromophenol
blue]. The samples were analysed on 6.5% polyacrylamide
gels (30:0.8, acrylamide: bisacrylamide); the buﬀer in the
gel and tanks was TBE–SDS (0.1% SDS, 100mM Tris
base, 100mM boric acid, 1mM EDTA; pH 8.3). Gels
were pre-run for 20min at 150V, 22C. Samples were
then loaded and the gels were run for a further 2 h
under the same conditions. Gels were dried, and bands
were visualized by phosphor-imaging. The cleavage rates
(k) presented in Table 2 were calculated from the data in
Figure 4C using the equation:
1 Cleaved DNA½ 
Total DNA½  ¼ e
kt,
assuming simple ﬁrst-order kinetics (see Figure 4B).
Structure analysis
The following crystal structures which include serine
recombinase catalytic domains are available: wild-type
gd resolvase [two structures, 2RSL and 1GDR, containing
four structurally distinct subunits; (25–27)]; a wild-type
gd resolvase dimer bound to site I DNA [1GDT; two
distinct subunits; (24)]; an activated mutant gd resolvase
N-terminal domain tetramer [2GM5; four distinct
subunits; (23)]; gd resolvase mutants in synaptic complexes
with cleaved site I DNA [three structures, with six distinct
subunit forms; 1ZR2, 1ZR4 and 2GM4; (22,23)]; a dimer
of Sin recombinase bound to DNA [2R0Q; two distinct
subunits (37)]; the catalytic domain of TP901 integrase
[3BVP; two distinct subunits (38)]; the catalytic domain
of a Clostridium recombinase [3G13; two distinct
subunits (39)]; and the catalytic domain of a Streptococcus
recombinase [3GUV; one subunit (40)]. Structures were
visualized and analysed using PyMOL (41).
RESULTS
Mutation of candidate active site residues of Tn3 resolvase
Mutations of putative active site residues were made in an
activated Tn3 resolvase variant (‘NM resolvase’) which
catalyses eﬃcient site I site I recombination in vivo and
in vitro (32,34). The selection of amino acid residues which
might contribute to the resolvase active site was based on
sequence alignment of serine recombinases [(4,5) and
M.R. Boocock, personal communication; Figure 1], and
ﬁndings from previous studies on mutants of Tn3
resolvase, gd resolvase, and other serine recombinases
[reviewed by Grindley (9) and Johnson (42); see Table 1].
The following criteria were used for selection: (i) The same
residue (or a conservative substitution with a similar
sidechain functional group) must be present at an equiv-
alent point in the sequence in most serine recombinases,
and in all the biochemically well-characterized members of
the resolvase/invertase group shown in Figure 1. (ii) The
residue must have a charged or polar sidechain which
might participate in catalysis. These criteria led to selec-
tion of 15 residues, including all those implicated in
catalysis by previous studies: Y6, R8, S10, Q14, Q19,
D36, S39, R45, D59, D67, R68, R71, E118, R119 and
R125 (Table 1). Conservative mutations of these residues
were made in order to minimize disruption of local and
global protein structure; thus, arginine residues were
changed to lysine (R ! K), aspartate to asparagine
(D ! N), glutamate to glutamine (E ! Q), glutamine
to glutamate (Q ! E), tyrosine to phenylalanine (Y !
F) and serine to alanine (S ! A). Each selected residue
(except D59) was also mutated to alanine, to probe the
eﬀect of loss of the polar sidechain. The mutant resolvases
were puriﬁed, and their biochemical properties were
characterized as described in the following sections. In
preliminary studies, the puriﬁed D59N mutant protein
proved to be very insoluble. As D59 is far from the
other active site residues (Table 1) and an alternative
function has been proposed for it [stabilization of a
Table 2. In vivo recombination and in vitro cleavage rates of NM
resolvase mutants
NM mutant In vivo resolution In vitro cleavage rate
NM ++ 1.00
Y6A  0.0002
Y6F  0.0002
R8A  <0.0001
R8K  0.0002
S10A  <0.0001
Q14A  0.0087
Q14E  0.0039
Q14R  0.016
Q14K  0.016
Q14N  0.018
Q14L  0.014
Q19A  0.0067
Q19E  0.0014
Q19R  <0.000l
Q19K  <0.0001
Q19N  0.0093
Q19L  0.0002
D36A  <0.0001
D36N  0.0004
S39A ++ 0.025
R45A  0.0034
R45K  0.022
D67A  0.017
D67N  0.018
R68A  0.0014
R68K  0.0016
R71A  0.0007
R71IC  0.0009
E118A  0.015
E118Q  0.019
R119A ++ 0.033
R119K ++ 0.038
R125A + 0.033
R125K + 0.028
(++) indicates high resolution activity in the E. coli colony colour
assay (i.e. pale colonies), (+) indicates partial resolution (pink
colonies), and () indicates no observable activity (red colonies) [see
ref. (32)]. The single-strand cleavage rates of the mutants were
estimated from the data shown in Figures 4C and 6B as described in
‘Materials and Methods’ section, and are expressed relative to the rate
of NM resolvase estimated from the 800 nM data shown in Figure 4B.
Note that the initial rates of those mutants that gave high levels of
cleavage in Figures 4C and 6B may be underestimated, due to
deviations from ﬁrst-order kinetics.
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sharp turn in the polypeptide; (25)], we decided not to
carry out any further work on it.
Catalytic properties of NM resolvase mutants
Recombination. A preliminary characterization of site
I site I recombination activity of the mutants was
carried out using a colony colour-based assay in E. coli
[(30), Table 2]. All mutations at eleven of the fourteen
chosen residues resulted in red colonies on MacConkey
agar plates, indicating defective resolution. Only S39A,
R119A, R119K, R125A and R125K had observable reso-
lution activity (pink or pale colonies).
Following puriﬁcation of all the mutant proteins, we
assayed their in vitro recombination activity on a site
I site I plasmid substrate (pAL225; Figure 3A).
Activated resolvases promote recombination between
the two site Is in a single pAL225 molecule to give inver-
sion and resolution products. Smaller amounts of
intermolecular recombination products may be observed.
Resolvase may fail to complete recombination, leaving
species with double-strand breaks at one or both of the
site Is, and a resolvase subunit attached via its active site
serine residue (S10) to each DNA 50-end (in the
experiments below, the attached resolvase is degraded by
treatment with protease). When the DNA is analysed
A
B
C
Figure 3. Recombination and DNA cleavage by NM resolvase active site mutants. (A) Diagram of the substrate plasmid pAL225, and its cleavage/
recombination products. DNA segments between the recombination sites and restriction sites are denoted with letters A–D, and their sizes are given
below the diagram. (B) Recombination of pAL225 by NM resolvase and mutants. Reactions were for 16 h at 37C (1 h for the parent NM resolvase).
Upper panel: samples were loaded on the gel after stopping the reaction, without further treatment. Lower panel: samples were ﬁrst digested with
PstI and HindIII. (C) Cleavage of pAL225 by NM resolvase and mutants in EG buﬀer, which contains 40% ethylene glycol. Reactions were for 16 h
at 37C. Samples were treated with protease K/SDS loading buﬀer prior to electrophoresis (no restriction enzyme treatment). The order of the
samples is as in Figure 3B. Annotation: sc, supercoiled plasmid substrate; nc, nicked circular substrate; rc, resolution products (free circles); int,
intermolecular recombination/cleavage product; 4.9 kb, full-length linear product of cleavage at one of the two site Is; 2.45 kb, products of cleavage at
both site Is; nr, non-recombinant restriction fragment; inv, inversion product restriction fragment; res, resolution product restriction fragment; cp,
cleavage product restriction fragment.
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without restriction enzyme digestion, products of
topoisomerization may be observed as ‘ladders’ of bands
between the supercoiled and nicked plasmid bands.
Topoisomerase activity requires transient cleavage and
re-ligation of at least one DNA strand. The reactions
shown in Figure 3B were carried out for 16 h at 37C
(except for the ‘parent’ NM resolvase; 1 h reaction) to
allow even very slow recombination, cleavage or
topoisomerase activity to be detectable. The results were
consistent with the in vivo assay described above, but
revealed low levels of activity by some of the defective
mutants. Under these conditions, NM resolvase
consumes more than half the pAL225 substrate in
<1min (34), so the predominance of substrate even after
16 h in many of the reactions shown in Figure 3B indicates
very severe inhibition of recombination and cleavage
activity. No recombination products were detectable in
the restriction digests of reactions with the S10, Y6, R8,
Q14, Q19, D36, R68 and R71 mutants, whereas all the
other mutants gave observable recombination products,
accompanied in some cases by products of DNA
cleavage at site I. Electrophoresis of the DNA without
restriction enzyme digestion revealed low cleavage
activity (a full-length linear band) and topoisomerase
activity by some recombination-defective mutants,
notably Q14A and the R68 and R71 mutants.
DNA cleavage. We also compared the activities of the
resolvase mutants in a reaction buﬀer that contains 40%
ethylene glycol (EG buﬀer); these conditions inhibit
rejoining of the pAL225 DNA ends after double-strand
cleavage by resolvase, leading to a 4.9 kbp linear product
if only one site is cleaved, or two linear fragments, both
2.45 kbp, if both sites are cleaved (Figure 3A). In EG
buﬀer NM resolvase cleaves more than half of the
pAL225 DNA in <1min at 37C (our unpublished
results). All the mutants that catalysed detectable recom-
bination (see above) also gave large amounts of cleavage
products after reaction for 16 h (Figure 3C); in general, the
extent of cleavage was higher than the extent of recombi-
nation. The 2.45 kbp band (indicating high cleavage
activity) was clearly visible in the products of the reactions
with S39A and both mutants of R45, D67, E118, R119
and R125. For mutants with lower activity, only the
4.9 kbp full-length linear band was obvious. All the
mutants of Y6, R8, S10, Q14, Q19, D36, R68 and R71
were either inactive or had only very weak cleavage
activity, reﬂecting the results of the recombination assay
(Figure 3B).
Single-strand cleavage assay. The eﬀects of mutations on
the rates of recombination and double-strand cleavage in
plasmid substrates may be ampliﬁed because formation of
the observed products requires multiple steps, each of
which might be aﬀected (at least two single-strand
cleavages to linearize the substrate, or four cleavages
followed by one or more re-ligation steps to make a
recombinant product). Strand cleavage activity might
also be masked by re-ligation of the cleaved DNA
strands. We therefore devised an assay in which
products are observed following cleavage of only one
DNA strand, and re-ligation is suppressed. Oligonucle-
otides were annealed to form a 70 bp site I-containing
DNA molecule (‘n-site I’) with a nick in the bottom
strand at the position where cleavage/re-ligation would
occur. Cleavage of the top strand of this substrate by
resolvase creates a ‘left’ half-site which does not undergo
re-ligation (Figure 4A), possibly because it has no
covalently attached resolvase subunit. The other, ‘right’
half-site, with its covalently attached resolvase subunit,
is able to make recombinant products (WMS and FJO,
unpublished results). Here, we end-labelled the left half-
site to observe cleavage of the top strand.
The n-site I substrate was cleaved rapidly by NM
resolvase (t1/2 <1min; Figure 4B). In contrast, Q19E
and both mutants of Y6, R8, S10, D36, R68 and R71
cleaved <10% of the substrate after 30min of reaction
(Figure 4C), corresponding to an estimated rate reduction
of 103-fold or more relative to NM resolvase (Table 2).
Binding and synapsis by NM resolvase mutants
A 70bp site I double-stranded oligonucleotide (sequence
shown in Figure 5A) was treated with NM resolvase or the
mutants, and the samples were separated by poly-
acrylamide gel electrophoresis under conditions that
favour observation of a ‘site I synapse’ comprising two
copies of site I bound together by a resolvase tetramer
(34) (Figure 5B). All the mutants were proﬁcient in
binding to site I (as can be seen by the reduced intensity
of the unbound band U, and the presence of retarded
bands corresponding to complexes with 1 or 2 resolvase
subunits), but some gave lower amounts of the site I
synapse band S than NM resolvase. Some of these
synapsis-defective mutants (most clearly, the mutants of
Y6 and D36) gave increased amounts of complexes of a
single site I with one or two resolvase subunits. For other
mutants (including Q19E, R119A and R119K), a smeary
band running between the positions of the site I synapse
and the complex of site I bound to 2 subunits suggested
partial dissociation of the site I synapse during
electrophoresis.
We analysed the eﬀects of resolvase concentration on
complex formation by NM resolvase and selected mutants
with defective synapsis properties (Figure 5C). The site I
synapse was the predominant bound species at all the NM
resolvase concentrations tested; there was only a trace of
the complex of site I with a resolvase monomer and no
distinct band corresponding to the 2-subunit complex. In
contrast, with the Y6A, Q19E and D36N mutants, the site
I synapse band was very faint even at very high resolvase
concentration, most of the DNA being in the complex of a
single site I with 2 resolvase subunits (and a smeary higher
band in the case of Q19E, as in Figure 5B). Instability of
the synapse might therefore contribute to the catalytic
deﬁciency of these mutants. The Y6F mutant was inter-
mediate in its behaviour, making substantial amounts of
synapse at high resolvase concentration.
Further analysis of mutants of Q14 and Q19
The functions of two glutamine residues, Q14 and Q19,
are especially obscure (see ‘Discussion’ section). Data for
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the Q ! A and Q ! E mutants are presented above, but
we decided to test the eﬀects of a wider range of mutations
of these two residues. Mutations to asparagine (Q ! N)
probed the eﬀects of shortening the side chain by one
methylene group while retaining the amide functional
group; mutations to arginine or lysine (Q ! R, Q ! K)
introduced a positive charge which might strengthen any
interactions of the sidechain with the negatively charged
DNA backbone; and mutations to leucine (Q ! L)
replaced the glutamine sidechain with a similar-sized but
hydrophobic one.
None of the Q14 or Q19 mutants gave recombination
products from pAL225, even after 16 h (Figure 6A, top
panel). However, the assay in EG buﬀer (Figure 6A, lower
panel) revealed cleavage activity by Q19N and all the Q14
mutants except Q14E. The active mutants also displayed
some topoisomerase activity, and thus they can promote
ligation as well as cleavage. The assay with n-site I
(Figure 6B) revealed single-strand cleavage by all the
Q14 mutants, along with Q19N, Q19A and Q19E.
The mutations of Q14 and Q19 did not seriously impair
binding or synapsis (Figure 6C), except for Q14E and
Q19E where glutamine is replaced by the negatively
charged glutamate. Surprisingly, mutation of Q14 to the
positively charged residues arginine and lysine (Q14R and
Q14K) signiﬁcantly increased the amount of site I synapse
observed in this assay. Some Q19 mutants showed reduced
binding of site I, but all formed a clear synapse band
except Q19E (and a retarded band seen with Q19E can
be interpreted as evidence for an unstable synapse; see
above).
DISCUSSION
Mutations of several of the fourteen chosen candidate
catalytic residues have very large eﬀects on the rate of
A
B
C
Figure 4. Single-strand cleavage assay. (A) Cleavage of n-site I by NM resolvase. The 70 bp n-site I has a nick at the scissile position on the bottom
strand; its sequence is otherwise identical to the site I substrate shown in Figure 5A. The 50-end at the nick is phosphorylated (incorporated during
chemical synthesis), and the 50-end of the top strand was end-labelled with 32P (asterisk in diagram). Cleavage of n-site I by resolvase generates a
35 bp labelled half-site product, and an unlabelled resolvase–DNA covalent complex, as shown. (B) Left panel: time course of cleavage of n-site I by
NM resolvase (concentration 400 nM). Aliquots were stopped at the times shown, and separated on a 6.5% polyacrylamide gel. Right panel: data
from the gel shown on the left, and a corresponding time course at 800 nM NM resolvase, were quantitated and plotted. (C) Cleavage of n-site I by
NM resolvase and mutants (800 nM). Reactions were for 30min at 37C. The percentage of cleavage product is indicated below each lane.
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catalysis by NM resolvase. The eﬀects of mutations of Y6,
R8, S10, D36, R68 and R71 are especially strong, with
complete abolition of recombination activity (Figure 3)
and 103-fold reduction or more in the rate of single-
strand cleavage (Figure 4 and Table 2), consistent with
key roles of these sidechains in catalysis. Mutations of
ﬁve other residues (Q14, Q19, R45, D67, E118) had
large but less extreme eﬀects. In previous studies on
topoisomerases, a residue whose substitution by alanine
resulted in a reaction rate reduction of 102-fold was
deemed to be ‘essential’ for catalysis (35). By this criterion
Q14, Q19 and R45 would be essential along with Y6, R8,
S10, D36, R68 and R71, but we regard the latter group as
being more important for catalysis because the eﬀects of
their mutations are about an order of magnitude larger.
None of the mutations abolished binding of NM resolvase
to site I, and none completely inhibited site I synapse for-
mation, but there were some striking eﬀects on the
amounts of synapse observed (discussed further below).
A number of serine recombinase crystal structures are
now available; some are of the proteins alone and others
are of complexes with DNA (see ‘Materials and Methods’
section). Below, we discuss our results in the context of
these structures, which should give us insight into the
possible arrangement of residues at the active site for
catalysis of DNA cleavage and rejoining, and how the
active site could be assembled. It is worth noting here
that the mutation-based strategy used in this study
provides information on the roles of the amino acid
sidechains, but not on any catalytic roles of main-chain
atoms.
Residues S10, Y6, R8 and D36
The function of the S10 sidechain –OH as the nucleophile
that attacks the scissile phosphodiester is well established
(see ‘Introduction’ section). Therefore, as expected, the
S10A mutant of NM resolvase was completely inactive
in our assays for recombination, cleavage and
topoisomerization. The S10A mutation also causes some
reduction in the extent of binding and synapsis of site I
(Figure 5 and data not shown), in accord with previous
reports of eﬀects of catalytic serine mutations on binding
to the recombination site (7,20).
A
B
C
Figure 5. Binding and synapsis by NM resolvase and its mutants. (A) The 70 bp double-stranded site I oligonucleotide used in these experiments.
The site I sequence is boxed. The top strand was 50-end-labelled with 32P as shown (asterisk). (B) Binding/synapsis assay. The concentration of the
resolvase was 400 nM in all samples. Bands corresponding to unbound site I DNA, complexes of site I with 1 or 2 resolvase subunits, and site I
synapse are indicated by U, 1, 2 and S, respectively (34). Lanes are collated from multiple gels. (C) Concentration dependence of binding/synapsis by
NM resolvase and selected mutants. Assays were as in B, except that the resolvase concentrations were varied (100, 200, 400, 800 nM).
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The functions of three other residues where mutations
are very deleterious (Y6, R8 and D36) may be
interconnected. All three residues are highly conserved in
the serine recombinases, though the D36 equivalent is
sometimes glutamate instead of aspartate, and the Y6
equivalent is a valine in one well-characterized enzyme
[Bxb1 integrase (43); Figure 1]. In previous studies, the
Y6F mutant of wild-type Tn3 resolvase was found to be
almost inactive (10), but weak cleavage, ligation and
topoisomerase activity by the gd resolvase Y6F mutant
was observed (11). Y6 is buried in the hydrophobic core
of the catalytic domain, quite far from S10. In most of the
structures the hydroxyl group of the Y6 sidechain is within
hydrogen-bonding distance of the carboxyl group of D36
or its equivalent (as in Figure 7B). D36 is closer to the
surface of the protein and also contacts mainchain atoms
at the start of the B-helix. The Y6 hydroxyl is also close
to the guanidinium moiety of the R8 sidechain, and in
one structure (2GM5) appears to be interacting with it
(Figure 7B). In turn, R8 is close to S10 and the DNA
(in 1ZR2, 1ZR4 and 2GM4), its guanidinium group
being within hydrogen-bonding distance of the non-
bridging oxygen atoms of the phosphodiester attached to
S10 (Figure 7A). It has been proposed that interactions by
Y6 and D36 might help to maintain the tertiary structure
of the active site region (24,11), but the very large eﬀects of
Y6 and D36 mutations on cleavage and recombination
that we observe are also consistent with a more direct
role in catalysis.
A
B
Figure 7. Sidechain interactions in the resolvase active site. (A) View of
the 1ZR4 crystal structure [subunit A; (22)] showing R8, Q19, D67,
R68 and R71 clustered around S10 which is covalently attached to the
50 phosphate of the cleaved site I DNA. The dashed lines indicate
putative hydrogen-bonding interactions, and the dotted line indicates
an apparent interaction between the sidechains of R8 and R68 (N–N
distance 3.3 A˚). (B) Interactions involving Y6, R8, D36 and R71 in one
subunit (A) of the mutant gd resolvase tetramer structure 2GM5 (23).
The N–N distance between R8 and R71 (dotted line) is 3.1 A˚. This
structure contains no DNA. The protein has the catalytic residue
mutation R68H.
A
B
C
Figure 6. Properties of Q14 and Q19 mutants. Assays in parts A, B
and C were as in Figures 3, 4 and 5 respectively. The results for Q14A,
Q14E, Q19A and Q19E shown in Figures 3, 4 and 5 are included again
here to allow comparison with the other mutants. (A) In vitro recom-
bination (upper panel) and cleavage in EG buﬀer (lower panel) of
plasmid substrate pAL225. (B) Single-strand cleavage assay on n-site
I. (C) Binding/synapsis of site I.
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A relationship between the roles of D36 and Y6 is
supported by our results, which show that mutants of
these residues behave very similarly in binding/synapsis
assays; they give reduced amounts of the site I synapse
band and increased amounts of complexes with a single
site I (Figure 5), thus apparently reverting to more ‘wild-
type’ behaviour compared to the synapsis-proﬁcient NM
resolvase (34). However, the Y6F mutant does give a
strong synapse band at higher protein concentration
(Figure 5C), so its catalytic defect is not simply due to
lack of synapsis.
The base that abstracts a proton from the S10 hydroxyl
group during DNA cleavage and from the deoxyribose
30-hydroxyl in the re-ligation step has not been identiﬁed.
We speculate that the guanidinium moiety of R8 might
provide the strong base that would be necessary to
deprotonate these rather non-acidic hydroxyl groups. R8
is positioned appropriately with respect to the scissile
DNA phosphodiester, and might also interact with Y6
(see above). The role of Y6 might be to facilitate
removal of a proton from R8 to form the base, and the
D36 carboxylate might be the ultimate proton acceptor.
The arginine sidechain has been deduced to act as a base
in a number of enzyme active sites; in some cases, an
interaction between an arginine guanidinium and a
nearby carboxylate is proposed to lower the arginine
pKa and thus facilitate deprotonation to form a base
(44). In resolvase, the interaction of R68 and D67
conforms to this model, but the D67 sidechain is not
essential (see below). However, R8 might have an analo-
gous relationship with a carboxylate group, being linked
to D36 via the Y6 hydroxyl. Interestingly, the guani-
dinium group of R8 also appears to associate with the
guanidinium group of another arginine sidechain in
1ZR4 (R68; Figure 7A) and in 2GM5 (R71; Figure 7B).
The other conserved arginines
Unlike many enzymes that promote cleavage of
phosphodiester bonds, resolvase-catalysed recombination
does not require any divalent metal ions (45–47). Metal
ions (usually Mg2+) are often assigned the role of with-
drawing electrons from the phosphorus atom and
stabilizing negative charge on the oxygen atoms of the
phosphodiester in the transition state (29), but resolvase
(and other serine recombinases) presumably uses posi-
tively charged amino acid sidechains such as that of
arginine instead (1,9,28). The candidates for this role in
Tn3 resolvase are R8, R45, R68, R71, R119 and R125.
R119 and R125 are quite distant from the scissile phos-
phate in the resolvase–DNA structures, and the R119A
and R125A mutants are proﬁcient for cleavage and
recombination, so these residues apparently have non-
catalytic roles. The mutants are however aﬀected in
synapsis (Figure 5). A regulatory function for R119 and
R125 in the rotation step of strand exchange has been
proposed (1,22).
R45 is closer to the scissile phosphate, though it does
not contact it in any of the structures. R45 has been
suggested to have a structural role, to ‘close a lid’
formed by the loop of residues 37–45 over Y6 and other
active site residues by contacting the carboxylate of D75
(27). The NM resolvase mutants R45A and R45K retain
cleavage and recombination activity (Figure 3), support-
ing the idea of a non-catalytic function.
Mutations of the other three arginine residues, R8, R68
and R71, have the most severe eﬀects on catalysis.
A possible role for R8 as a base is discussed above.
The sidechains of both R8 and R68 are apparently in
contact with the non-bridging oxygens of the phosphate
covalently attached to S10 in the crystal structures of
cleaved intermediates (1ZR2, 1ZR4 and 2GM4), and
therefore are strong candidates for providing stabilizing
positive charge during catalysis (1; Figure 7A). The R71
sidechain is also quite close to the scissile phosphate, but it
has not been observed to contact it; in 1ZR4 it interacts
with an adjacent phosphate. The mutants R71K and
R71A are not inert but cleavage and recombination are
severely reduced (Figures 3 and 4), so R71 may well also
be involved in the mechanism of phosphate activation.
S39, D67 and E118
The mutants of these three residues retained substantial
cleavage and recombination activities, suggesting non-
catalytic roles [as was concluded previously for S39;
(19)]. The contact between the D67 carboxylate
[previously proposed as the general base; (48)] and the
R68 guanidinium group (Figure 7A) might be involved
in active site structural organization, as has been suggested
by Yuan et al. (38) for the corresponding TP901 integrase
residue D81. E118 is on the 1–2 dimer interface; the two
E118 sidechains in the gd resolvase dimer (and the corre-
sponding residues in structures of other serine recombi-
nases) apparently contact each other. The E118
sidechains have moved apart in the structures of cleaved
intermediates, e.g. 1ZR4, and are quite far from the
scissile phosphates in all the structures, but they might
be much closer to the DNA immediately prior to
cleavage, and thus might have an accessory role in
catalysis.
Q14 and Q19
We were intrigued by the conservation of these two
glutamine residues. The Q14 sidechain is on the surface
of the protein and does not come close to the DNA nor
any of the other potential active site residues in any of the
structures, but it is clearly important; all the mutants were
severely recombination-defective (Figure 6A and Table 1).
On the other hand, all the Q14 mutants showed substan-
tial activity in the single-strand cleavage assay (Figure 6B).
Mutation of Q14 to a positively charged residue (Q14R,
Q14K) increased the yield of site I synapse (Figure 6C,
and data not shown), whereas a negatively charged
sidechain (Q14E) decreased the amount of synapse and
overall binding to site I, suggesting that Q14 might be
close to the negative charge of the DNA backbone in
complexes of resolvase with DNA. However, we still
have no deﬁnite proposal for the function of this
residue. The Q19A, Q19E and Q19N mutants retained
some cleavage activity; Q19N was the most active, so
H-bonding functionality at this position might be
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important. In the crystal structures, the carboxamide
sidechain of Q19 is within H-bonding distance of the
main-chain amino and carboxyl groups of R8, as well as
the sidechain of another active site residue R68 (in
1GDT), so its role might be structural, to orient the R8
and R68 residues appropriately in the active site.
Involvement of active site residues in synapsis
A surprising ﬁnding of our study is that mutations of
several of the putative active site residues of resolvase
aﬀect the amount of the site I synapse (and to a lesser
extent, complexes with a single site I) (Figure 5 and 6).
It might have been predicted that mutations of any of the
six conserved arginine residues that remove the positive
charge of the sidechain would reduce aﬃnity for the neg-
atively charged DNA, but this was not the case except for
the E-helix residues R119 and R125, which are non-
essential for catalysis. The strongest ‘synapsis-down’
eﬀects were instead seen with the mutations of Y6 and
D36. The Q14E and Q19E mutations also substantially
reduced the amount of synapse observed on the gels,
whereas other Q14 and Q19 mutations had smaller
eﬀects or even increased the amount of synapse (Q14K
and Q14R). Reduced binding and synapsis by the S10A
mutant was also noted (see above).
Synapsis of two site Is is proposed to occur by interac-
tion of two site I-resolvase dimer complexes (22,34). The
synaptic interface observed crystallographically involves
residues that are far from the DNA, as does a hypothetical
interface at initiation of synapsis (22,31,32), and none of
the candidate catalytic residues mutated here are proposed
to be involved. We hypothesize that assembly of the func-
tional active site on the DNA is coupled to
conformational changes in other parts of the resolvase
tetramer which stabilize the site I synapse. Mutations of
active site residues might thus disrupt this process and
reduce synapse stability. In stable pre-cleavage synapses
(such as those we see in our assays) the active site might be
more fully assembled than it is in the current crystal
structures, with the resolvase tetramer poised to initiate
catalysis of strand cleavage. The pre-cleavage synapse,
which has so far only been characterized at low resolution
(15) is thus a very attractive target for future higher-
resolution structural studies.
Substrate-induced organization of functional active
sites might be common in enzymes that catalyse DNA
phosphoryl transfer reactions; other proteins for which a
similar paradigm has been proposed include EcoRI
endonuclease (49), MutH (50), topoisomerase I (51) and
the tyrosine recombinases (52). This proposed link
between resolvase-mediated catalysis and site I synapsis
may be only one of a series of ‘checkpoints’ in the mech-
anism of wild-type resolvase which serve to ensure that
catalysis occurs only in the biologically appropriate
circumstances. Cooperative assembly of Tn3 resolvase
monomers to form dimers on the binding sites of res
may ensure high speciﬁcity of binding (53); the require-
ment for a synaptic complex involving intertwining of the
two res sites mediated by a complex network of protein–
protein and protein–DNA interactions provides speciﬁcity
for recombination between sites in the same DNA
molecule and in direct repeat (54); assembly of Tn3
resolvase subunits into functional tetramers occurs only
at synapsis of two site Is (34); following active site
assembly, the catalytic events themselves (four strand
cleavages, rotation, and four strand re-ligations) may be
orchestrated to ensure an ‘all or nothing’ reaction; and
features of the natural synaptic complex limit the strand
exchange mechanism to a single round, giving the
biologically relevant resolution products.
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